Evidence map›Paper›PMID 41222163›Full record

ArticleHuman brain mapping2025

Utility of Harmonisation for Fixel-Based Metrics in Travelling Subjects and Alzheimer's Disease Data.

Rui Zou, Koji Kamagata, Remika Mito, Kaito Takabayashi, Christina Andica, Wataru Uchida, Sen Guo, Takafumi Kitagawa, Shohei Fujita, Akiko Uematsu and 4 more

Abstract readMulticenter Study
In one paragraph

Article in Human brain mapping, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Rui ZouDepartment of Radiology, Juntendo University Graduate School of Medicine, Tokyo, Japan.ORCID 0009-0008-7961-5687
Koji KamagataDepartment of Radiology, Juntendo University Graduate School of Medicine, Tokyo, Japan.ORCID 0000-0001-5028-218X
Remika MitoDepartment of Psychiatry, The University of Melbourne, Melbourne, Victoria, Australia.ORCID 0000-0003-3945-2293
Kaito TakabayashiDepartment of Radiology, Juntendo University Graduate School of Medicine, Tokyo, Japan.
Christina AndicaDepartment of Radiology, Juntendo University Graduate School of Medicine, Tokyo, Japan.ORCID 0000-0002-9339-6950
Wataru UchidaDepartment of Radiology, Juntendo University Graduate School of Medicine, Tokyo, Japan.
Sen GuoDepartment of Radiology, Juntendo University Graduate School of Medicine, Tokyo, Japan.
Takafumi KitagawaDepartment of Radiology, Juntendo University Graduate School of Medicine, Tokyo, Japan.
Shohei FujitaDepartment of Radiology, Juntendo University Graduate School of Medicine, Tokyo, Japan.
Akiko UematsuLaboratory for Brain Connectomics Imaging, RIKEN Center for Biosystems Dynamics Research, Kobe, Hyogo, Japan.
Norihide MaikusaCenter for Evolutionary Cognitive Sciences, Graduate School of Art and Sciences, The University of Tokyo, Tokyo, Japan.ORCID 0000-0003-0943-4684
Shinsuke KoikeCenter for Evolutionary Cognitive Sciences, Graduate School of Art and Sciences, The University of Tokyo, Tokyo, Japan.ORCID 0000-0002-3375-236X
Shigeki AokiDepartment of Radiology, Juntendo University Graduate School of Medicine, Tokyo, Japan.
Alzheimer's Disease Neuroimaging Initiative

Funding

Alzheimer's Disease Neuroimaging Initiative - SupplementU01AG024904 · NIA · NORTHERN CALIFORNIA INSTITUTE RES &EDUC · PI WEINER, MICHAEL W · 2004 to 2015
$121.0M
Australian Research Council Discovery Early Career Researcher Award DE240101035Brain/MINDS Beyond Program of the Japan Agency for Medical Research and Development (AMED) JP18dm0307004Brain/MINDS Beyond Program of the Japan Agency for Medical Research and Development (AMED) JP19dm0307101Brain/MINDS Beyond Program of the Japan Agency for Medical Research and Development (AMED) JP21wm0425006Brain/MINDS Beyond Program of the Japan Agency for Medical Research and Development (AMED) JP24wm0625310Japan Society for the Promotion of Science (KAKENHI) 23H02865Japan Society for the Promotion of Science (KAKENHI) 23K14927Japan Society for the Promotion of Science (KAKENHI) 23K27556JST FOREST Program JPMJFR231PJuntendo Research Branding Project for Training Experts in Statistical SciencesNIA NIH HHS U01 AG024904
6 · The paper itself

Abstract

Fixel-based analysis (FBA) is an advanced diffusion MRI analysis technique that facilitates the evaluation of white matter microstructure within 'fixels' (specific fibre populations within a voxel). In recent years, FBA has gained prominence for its ability to better characterise fibre tract-specific changes than the more conventional diffusion MRI approaches and has shown promise in elucidating the pathophysiology of psychiatric and neurological diseases. However, FBA has been predominantly limited to single-centre studies, minimising the generalisability of the technique. In this study, the popular ComBat harmonisation technique was adapted for whole-brain FBA of diffusion MRI data. The study evaluates the effectiveness of ComBat in harmonising FBA metrics of fibre density, fibre cross-section and the combined metric of fibre density and cross-section in a large travelling subject dataset (n = 49, scan = 162). Participants were scanned across multiple centres, using different scanner models and imaging protocols, and FBA metrics were compared under these varying conditions before and after harmonisation. In addition, the impact of ComBat harmonisation on disease-related findings was evaluated in an independent multi-centre Alzheimer's disease (AD) dataset, by comparing the same fixel-based measures in patients with AD (n = 27) to those in cognitively normal control participants (n = 29) before and after ComBat harmonisation. We demonstrated that ComBat harmonisation effectively mitigated variability across scanner sites, scanner models, and protocols, in the travelling subject dataset, thus enhancing the comparability of FBA metrics. Notably, ComBat harmonisation improved the detection of AD-related changes in the fornix, a critical white matter tract associated with cognitive function, and strengthened the correlations between FBA metrics and cognitive scores. These results underscore the potential of ComBat harmonisation in enhancing the reliability of multi-centre neuroimaging studies, supporting the use of harmonisation techniques for accurate detection of disease-specific changes in neurodegenerative conditions. The ability to perform ComBat harmonisation within the whole-brain FBA pipeline may help further this fibre-specific technique into large-scale multi-centre studies.

Indexed as

Alzheimer DiseaseDiffusion Magnetic Resonance ImagingDiffusion Tensor ImagingImage Processing, Computer-AssistedNeuroimagingWhite MatterAgedFemaleHumansMaleMiddle AgedAlzheimer's diseaseComBat harmonisationfixel‐based analysismulti‐centre dMRI studiestravelling subject

Identifiers

PMID41222163
PMCPMC12606591

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.